Latest Prostate cancer Stories
TUEBINGEN, Germany, July 16, 2014 /PRNewswire/ -- Funds will be used to complete phase 3 study with IMA901 and to invest in the expansion of immatics' Human Immunopeptidome
New research from The University of Texas MD Anderson Cancer Center is shedding light on the important role a diagnosing urologist plays in whether older men with low-risk prostate cancer receive treatment for their disease, and if so, the type of treatment they receive as a result.
SAN ANTONIO, July 14, 2014 /PRNewswire/ -- GenSpera, Inc.
Vasectomy was associated with a small increased risk of prostate cancer, and a stronger risk for advanced or lethal prostate cancer.
Patient was previously enrolled in Can-Fite's Phase I/II liver cancer study and has survived for about 5-years using the Company's cancer drug; The global liver cancer drug market is expected to exceed
Tenacious Lung Cancer Survivor Fights for Her Life and the Lives of Others WASHINGTON, July 10, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation announces Bonnie J.
LONDON, July 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
LONDON, ON, July 9, 2014 /CNW/ - Focal Healthcare (Focal) was founded as a spin-off company out of the
HealthTronics, Inc., a leading provider of integrated urological and interventional radiology products and services, has signed a distribution agreement through its Endocare, Inc.
New Jersey CyberKnife physicians part of nationwide group analyzing value of RSSearch Registry TOMS RIVER, N.J., July 8, 2014 /PRNewswire/ -- Physicians at New Jersey CyberKnife, a
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.
More Images (2 images) »